Randomized trial on acute toxicities of weekly vs three-weekly cisplatin-based chemoradiation in head and neck cancer.

Cancer Rep (Hoboken) · 2022 · PMC8789619 · PMID 34101389

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

26 Current trial showed a trend toward a more cumulative dose of cisplatin in the weekly schedule, which may, in turn, improve treatment outcomes.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.